Gian Lifecare Return on Equity (ROE) History

Gian Lifecare Ltd Return on Equity

The Gian Lifecare Ltd Return on Equity is a key financial metric used by investors to evaluate Gian Lifecare Ltd's valuation, profitability, and overall financial performance. Tracking the Gian Lifecare Ltd Return on Equity helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Gian Lifecare Ltd (NSE: , BSE: 542918) is currently trading at ₹7.81, with a market capitalization of ₹81.49M. As a leading company in the Health services sector and Medical/Nursing services industry, monitoring the Gian Lifecare Ltd Return on Equity is essential for fundamental analysis.

Gian Lifecare Ltd Return on Equity Current Value

The current Gian Lifecare Ltd Return on Equity stands at -0.19.

The Gian Lifecare Ltd Return on Equity has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.

Gian Lifecare Ltd Return on Equity Historical Trend

The Gian Lifecare Ltd Return on Equity has shown the following historical trend:

• 2024: -0.19
• 2023: 24.15
• 2022: 7.30
• 2021: 36.92
• 2020: 23.33

The decline in Gian Lifecare Ltd Return on Equity indicates improving financial efficiency or better earnings growth.

What Gian Lifecare Ltd Return on Equity Indicates for Investors

The Gian Lifecare Ltd Return on Equity plays a crucial role in understanding the company's financial health and valuation.

ROE indicates how efficiently the company generates returns for shareholders.

Gian Lifecare Ltd Return on Equity Analysis Summary

The Gian Lifecare Ltd Return on Equity remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Gian Lifecare Ltd Return on Equity should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Gian Lifecare Ltd Return on Equity helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.